e.g. Tata motors, Reliance MF, 500570

Tatva Chintan Pharma Chem Ltd. - Research Center

543321 TATVA Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 366.42 378.68 403.04 427.81 291.19
Expenses
Material consumed 206.67 185.73 239.15 209.49 151.79
Manufacturing expenses 34.44 34.78 23.61 22.62 9.92
Personnel expenses 52.92 54.76 38.60 30.81 24.13
Selling expenses - - - - -
Adminstrative expenses 46.54 36.54 47.01 59.12 40.16
Expenses capitalised - - - - -
Cost of sales 340.57 311.81 348.37 322.04 226.00
Operating profit 25.84 66.87 54.68 105.77 65.19
Other recurring income 3.56 7.51 5.68 10.51 5.10
Adjusted PBDIT 29.41 74.37 60.36 116.28 70.29
Financial expenses 1.29 6.51 8.38 4.83 4.21
Depreciation 27.65 25.60 9.55 8.18 6.73
Other write offs - - - - -
Adjusted PBT 0.46 42.27 42.42 103.27 59.35
Tax charges 0.13 12.92 -1.63 7.28 7.99
Adjusted PAT 0.33 29.35 44.05 95.99 51.36
Non recurring items -0.22 - -3.59 - -
Other non cash adjustments - - - - -
Reported net profit 0.11 29.35 40.47 95.99 51.36
Earnigs before appropriation 298.20 303.26 278.34 237.88 157.97
Equity dividend 4.68 4.68 4.43 - 4.02
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 293.53 298.58 273.91 237.88 153.95
Close
Add Tatva Chintan Pharma Chem Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Tatva Chintan Pharma Chem Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback